By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteome Sciences and the Moffitt Cancer Center have struck a partnership to research ways to develop assays that can be adapted for analyzing tumors, the UK-based company said today.

Proteome Sciences said it will work with Moffitt, located in Tampa, Fla., to develop mass spectrometry assays that can measure important signalling and repair pathway proteins for use in tumor biopsy analysis in the clinic.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.